Illumina Applies CE Mark to MiSeqDx for Cystic Fibrosis Testing; Other MiSeq IVD Assays to Come | GenomeWeb

As an indication that next-generation sequencing is making its way into in vitro diagnostics, Illumina said this week that it has applied Europe's CE mark to the MiSeqDx Cystic Fibrosis System, a diagnostic version of its MiSeq sequencer with two associated cystic fibrosis assays and dedicated software.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.